Bulk Manufacturer of Controlled Substances Application; Promega Corporation, 13881 [2025-05283]
Download as PDF
<![CDATA[
Federal Register / Vol. 90, No. 58 / Thursday, March 27, 2025 / Notices
established a schedule for the final
phase of the antidumping duty
investigations (89 FR 91423, November
19, 2024). On March 19, 2025, counsel
for Eastman Chemical Company
(‘‘Eastman’’) and counsel for BASF
Corporation (‘‘BASF’’) filed requests to
appear at the hearing. No other parties
submitted a request to appear at the
hearing. On March 20, 2025, counsel for
Eastman filed a request that the
Commission cancel the scheduled
hearing for these investigations and
withdrew its request to appear at the
hearing. On March 20, 2025, counsel for
BASF withdrew its request to appear at
the hearing. Counsel indicated a
willingness to respond to any
Commission questions in lieu of an
actual hearing. Consequently, the public
hearing in connection with these
investigations, scheduled to begin at
9:30 a.m. on Tuesday, March 25, 2025,
is cancelled. Parties to these
investigations should respond to any
written questions posed by the
Commission in their posthearing briefs,
which are due to be filed on April 1,
2025.
For further information concerning
these investigations see the
Commission’s notice cited above and
the Commission’s Rules of Practice and
Procedure, part 201, subparts A and B
(19 CFR part 201), and part 207,
subparts A, D, E, and F (19 CFR part
207).
Authority: These investigations are
being conducted under authority of title
VII of the Tariff Act of 1930; this notice
is published pursuant to § 207.21 of the
Commission’s rules.
SUPPLEMENTARY INFORMATION listed
below for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants, therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before May 27, 2025. Such persons
may also file a written request for a
hearing on the application on or before
May 27, 2025.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on February 26, 2025,
Promega Corporation, 3075 Sub Zero
Parkway, Fitchburg, Wisconsin 53719,
applied to be registered as bulk
manufacturer of the following basic
class(es) of controlled substance(s):
By order of the Commission.
Issued: March 24, 2025.
Lisa Barton,
Secretary to the Commission.
Psilocybin ........................
Psilocyn ...........................
[FR Doc. 2025–05271 Filed 3–26–25; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Controlled substance
I
Drug
code
Schedule
7437
7438
I
I
I
The company plans to bulk
manufacture the listed controlled
substances as Active Pharmaceutical
Ingredients (API) for sale to its
customers. No other activities for these
drug codes are authorized for this
registration.
Drug Enforcement Administration
Matthew Strait,
Deputy Assistant Administrator.
[Docket No. DEA–1526]
[FR Doc. 2025–05283 Filed 3–26–25; 8:45 am]
BILLING CODE P
lotter on DSK11XQN23PROD with NOTICES1
Bulk Manufacturer of Controlled
Substances Application; Promega
Corporation
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Promega Corporation has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
SUMMARY:
VerDate Sep<11>2014
17:43 Mar 26, 2025
Jkt 265001
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. 25–19]
Willard J. Davis, D.O.; Decision and
Order
On November 13, 2024, the Drug
Enforcement Administration (DEA or
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
13881
Government) issued an Order to Show
Cause (OSC) to Willard J. Davis, D.O., of
Round Rock, Texas (Respondent). OSC,
at 1, 4. The OSC proposed the
revocation of Respondent’s DEA
Certificate of Registration No.
BD9134254, alleging that Respondent’s
DEA registration should be revoked
because Respondent is ‘‘without
authority to handle controlled
substances in the State of Texas, the
state in which [he is] registered with
DEA.’’ Id. at 2 (citing 21 U.S.C.
824(a)(3)).
On December 10, 2024 Respondent
filed a request for a hearing. On
December 30, 2024, the Government
filed a Motion for Summary Disposition,
which Respondent opposed. On January
23, 2025, Administrative Law Judge
Teresa A. Wallbaum (the ALJ) granted
the Government’s Motion for Summary
Disposition and recommended the
revocation of Respondent’s registration,
finding that because Respondent lacks
state authority to handle controlled
substances in Texas, the state in which
he is registered with DEA, ‘‘[t]here is no
genuine issue of material fact in this
case.’’ Order Granting the Government’s
Motion for Summary Disposition, and
Recommended Rulings, Findings of
Fact, Conclusions of Law, and Decision
of the Administrative Law Judge (RD), at
6. Respondent did not file exceptions to
the RD.
Having reviewed the entire record, the
Agency adopts and hereby incorporates
by reference the entirety of the ALJ’s
rulings, findings of fact, conclusions of
law, and recommended sanction as
found in the RD and summarizes and
expands upon portions thereof herein.
Findings of Fact
On May 16, 2024, the Texas Medical
Board suspended Respondent’s Texas
medical license. RD, at 3.1 According to
Texas online records, of which the
Agency takes official notice,
Respondent’s Texas medical license
remains suspended.2 Texas Medical
Board Healthcare Provider Search,
https://profile.tmb.state.tx.us (last
visited date of signature of this Order).
Accordingly, the Agency finds that
Respondent is not currently licensed to
1 See also Government’s Notice of Filing of
Evidence and Motion for Summary Disposition,
Exhibit 1, at 3–6.
2 Under the Administrative Procedure Act, an
agency ‘‘may take official notice of facts at any stage
in a proceeding—even in the final decision.’’
United States Department of Justice, Attorney
General’s Manual on the Administrative Procedure
Act 80 (1947) (Wm. W. Gaunt & Sons, Inc., Reprint
1979).
E:\FR\FM\27MRN1.SGM
27MRN1
]]>Agencies
[Federal Register Volume 90, Number 58 (Thursday, March 27, 2025)]
[Notices]
[Page 13881]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-05283]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1526]
Bulk Manufacturer of Controlled Substances Application; Promega
Corporation
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Promega Corporation has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
Supplementary Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants, therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
May 27, 2025. Such persons may also file a written request for a
hearing on the application on or before May 27, 2025.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on February 26, 2025, Promega Corporation, 3075 Sub Zero
Parkway, Fitchburg, Wisconsin 53719, applied to be registered as bulk
manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Psilocybin.............................. 7437 I
Psilocyn................................ 7438 I
------------------------------------------------------------------------
The company plans to bulk manufacture the listed controlled
substances as Active Pharmaceutical Ingredients (API) for sale to its
customers. No other activities for these drug codes are authorized for
this registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2025-05283 Filed 3-26-25; 8:45 am]
BILLING CODE P
